14 results on '"Vanyan A"'
Search Results
2. Reports on establishing an ex situ site for ‘beautiful’ vavilovia (Vavilovia formosa) in Armenia
- Author
-
Akopian, Janna, Sarukhanyan, Nune, Gabrielyan, Ivan, Vanyan, Armen, Mikić, Aleksandar, Smýkal, Petr, Kenicer, Gregory, Vishnyakova, Margarita, Sinjushin, Andrey, Demidenko, Natalia, and Ambrose, Mike
- Published
- 2010
- Full Text
- View/download PDF
3. Human Cases of Tularemia in Armenia, 1996–2012
- Author
-
Marine Kotanyan, Artavazd Vanyan, Lilit Avetisyan, Karo Palayan, Nune Bakunts, Syuzanna Melikjanyan, and Marta A. Guerra
- Subjects
Adult ,Male ,0301 basic medicine ,Adolescent ,Steppe ,030106 microbiology ,Food Contamination ,Disease Outbreaks ,Tularemia ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Virology ,Environmental health ,medicine ,Humans ,030212 general & internal medicine ,Child ,Aged ,Retrospective Studies ,geography.geographical_feature_category ,Incidence (epidemiology) ,Foodborne outbreak ,Infant ,Outbreak ,Articles ,Armenia ,Middle Aged ,medicine.disease ,Infectious Diseases ,Geography ,Child, Preschool ,Waterborne pathogen ,Female ,Parasitology ,Rural area ,Food contaminant - Abstract
A retrospective analysis was conducted of human cases and outbreaks of tularemia in the Republic of Armenia from 1996 to 2012 utilizing geographic information system software. A total of 266 human cases of tularemia were recorded in Armenia from 1996 to 2012, with yearly incidence ranging from 0 to 5.5 cases per 100,000 people. Cases predominantly affected the male population (62.8%), 11–20 year age group (37.2%), agricultural workers (49.6%), and persons residing in rural areas (93.6%). In 2003, a waterborne outbreak involving 158 cases occurred in Kotayk Marz, and in 2007, a foodborne outbreak with 17 cases occurred in Gegharkunik Marz, attributed to exposure of food products to contaminated hay. Geospatial analysis of all cases showed that the majority were associated with the steppe vegetation zone, elevations between 1,400 and 2,300 m, and the climate zone associated with dry, warm summers, and cold winters. Characterization of these environmental factors were used to develop a predictive risk model to improve surveillance and outbreak response for tularemia in Armenia.
- Published
- 2017
- Full Text
- View/download PDF
4. Multicountry Analysis of Spectrum of Clinical Manifestations of Children5 Years of Age Hospitalized with Diarrhea
- Author
-
Jillian, Murray, S Yati, Soenarto, Nenny S, Mulyani, Pushpa S, Wijesinghe, Evans M, Mpabalwani, Julia C, Simwaka, Belem, Matapo, Jason M, Mwenda, Gayane, Sahakyan, Svetlana, Grigoryan, Artavazd, Vanyan, Sergey, Khactatryan, Jennifer, Sanwogou, Lúcia, Helena de Oliveira, Gloria, Rey-Benito, Gagandeep, Kang, Fatima, Serhan, Jacqueline E, Tate, Negar, Aliabadi, Adam L, Cohen, and S, Babji
- Subjects
Male ,Persistent diarrhea ,Pediatrics ,Epidemiology ,lcsh:Medicine ,medicine.disease_cause ,spectrum ,multicountry analysis ,0302 clinical medicine ,Rotavirus ,Public Health Surveillance ,030212 general & internal medicine ,Severe diarrhea ,Vaccines ,clinical manifestations ,Vaccination ,Dispatch ,Armenia ,Rotavirus vaccine ,Bloody ,Hospitalization ,Diarrhea ,Infectious Diseases ,child surveillance ,Child, Preschool ,Female ,medicine.symptom ,Microbiology (medical) ,medicine.medical_specialty ,Bolivia ,030231 tropical medicine ,India ,Zambia ,Rotavirus Infections ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,children ,medicine ,El Salvador ,Humans ,lcsh:RC109-216 ,viruses ,hospitalizations ,business.industry ,Immunization Programs ,enteric infections ,lcsh:R ,Infant, Newborn ,Rotavirus Vaccines ,Infant ,Acute gastroenteritis ,Multicountry Analysis of Spectrum of Clinical Manifestations of Children <5 Years of Age Hospitalized with Diarrhea ,rotavirus ,Indonesia ,Paraguay ,business - Abstract
After introduction of rotavirus vaccine, other pathogens might become leading causes of hospitalizations for severe diarrhea among children
- Published
- 2019
5. Impact and Effectiveness of Monovalent Rotavirus Vaccine in Armenian Children
- Author
-
Ara Asoyan, Gayane Sahakyan, Liudmila Mosina, Karine Kocharyan, Tigran Avagyan, Annemarie Wasley, Margaret M. Cortese, Zaruhi Gevorgyan, Svetlana Grigoryan, Benjamin A. Lopman, Shushan Sargsyan, Umesh D. Parashar, Sergey Khactatryan, and Artavazd Vanyan
- Subjects
Diarrhea ,Male ,Rotavirus ,0301 basic medicine ,Microbiology (medical) ,Pediatrics ,medicine.medical_specialty ,030106 microbiology ,Vaccines, Attenuated ,medicine.disease_cause ,Rotavirus Infections ,Feces ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,030212 general & internal medicine ,Antigens, Viral ,Vaccine Potency ,Immunization Programs ,Armenian ,business.industry ,Vaccination ,Rotavirus Vaccines ,Infant ,Armenia ,Vaccine introduction ,Rotavirus vaccine ,Virology ,language.human_language ,Confidence interval ,Gastroenteritis ,Hospitalization ,Infectious Diseases ,Immunization ,Child, Preschool ,Epidemiological Monitoring ,language ,Immunization program ,business - Abstract
BACKGROUND The Republic of Armenia was 1 of the 2 earliest countries in the Newly Independent States to introduce rotavirus vaccine into its national immunization program to reduce the burden of rotavirus disease (documented to cause 38% of acute gastroenteritis hospitalizations [AGE] among children aged
- Published
- 2016
- Full Text
- View/download PDF
6. Influenza Sentinel Surveillance System in Surb Astvatsamayr Medical Center, 2013-15
- Author
-
Artavazd Vanyan, Liana Torosyan, and Lilit Avetisyan
- Subjects
education.field_of_study ,medicine.medical_specialty ,business.industry ,Medical record ,Respiratory disease ,Population ,sentinel surveillance ,Influenza a ,ISDS 2018 Conference Abstracts ,Armenia ,medicine.disease ,Respiratory pathogens ,Severe acute respiratory infection ,Age groups ,Emergency medicine ,SARI ,General Earth and Planetary Sciences ,Medicine ,Sampling (medicine) ,business ,education ,General Environmental Science ,case definition - Abstract
Objective The goal of this study was to identify gaps in the severe acute respiratory infection sentinel surveillance system at Surb Astvatsamayr Medical Center. Introduction Influenza is a priority in Armenia. There are two influenza surveillance systems in Armenia: population and sentinel. The medical center (MC) has been included in sentinel surveillance since 2012. In 2015 a study was undertaken to identify gaps in severe acute respiratory infection (SARI) sentinel surveillance system in Surb Astvatsamayr MC. Methods Medical records and reporting forms of SARI cases were generated for individuals meeting the case definition and analyzed for age groups, risk factors, sentinel surveillance detection methods, laboratory conformation, number of days hospitalized and reporting. Results In 2014, 3016 patients were admitted in the hospital with ARI, of whom 2982 were younger than 18 years. During the 2014-2015 influenza season (week 40, 2014-week 20, 2015), 77 swabs have been taken in total, of which five were influenza positive (4 B and 1 AH1N1). Also in the 2013-2014 influenza season, five samples tested positive (all influenza A). Sixty-one (48%) patients with respiratory disease met the WHO SARI case definition (2011), 84 (66%) of all reviewed patients would have met the SARI case definition. The numbers for the ICU (25 records reviewed) do not reflect the actual percentage of patients admitted with respiratory symptoms. The 33 additional cases taken from the sampling logbook were mainly hospitalized in the ICU. Influenza tests were performed on 34 patients (mainly ICU), five were positive for influenza (four B--all adults—and one AH1N1), and four tested positives for other respiratory pathogens (two RSV, one RV, one BV). All influenza positives had fever or a history of fever and 80% met the WHO SARI case definition (2011). Non-sampled cases generally have fewer reported symptoms, but still 44% of cases fits the WHO SARI case definition (2011). Conclusions The percentages of patients meeting the WHO SARI 2011 case definition and the WHO SARI 2014 definition shows that mainly caused by the absence of shortness of breath in the SARI 2014 definition 52% (2011) vs 66% (2014) in Surb Asvatsamayr. A large number of children from Neonatal and Children’s departments fulfil the SARI case definition and could potentially be swabbed in addition to ICU patients. There are gaps in WHO SARI case definitions. The sentinel surveillance system should be improved.
- Published
- 2018
7. Using pneumococcal and rotavirus surveillance in vaccine decision-making: A series of case studies in Bangladesh, Armenia and the Gambia
- Author
-
Adam L. Cohen, Sergey Khactatryan, Gayane Sahakyan, Fatima Serhan, Samir K. Saha, Shushan Sargsyan, Jason M. Mwenda, Karine Kocharyan, Maria Deloria Knoll, Martin Antonio, Syed M. A. Zaman, Svetlana Grigoryan, Artavazd Vanyan, Sebastien Antoni, Ara Asoyan, Danni Daniels, Senjuti Saha, Alvira Z. Hasan, Pushpa Ranjan Wijesinghe, and Zaruhi Gevorya
- Subjects
0301 basic medicine ,Burden of disease ,Rotavirus ,Surveillance data ,Decision Making ,Disease ,medicine.disease_cause ,Rotavirus Infections ,Pneumococcal Vaccines ,03 medical and health sciences ,0302 clinical medicine ,Policy decision ,Environmental health ,medicine ,Humans ,030212 general & internal medicine ,Disease burden ,Disease surveillance ,Bangladesh ,General Veterinary ,General Immunology and Microbiology ,Immunization Programs ,Public Health, Environmental and Occupational Health ,Rotavirus Vaccines ,Armenia ,Vaccination ,030104 developmental biology ,Infectious Diseases ,Molecular Medicine ,Gambia ,Business - Abstract
Pneumonia and diarrhea are the leading causes of child morbidity and mortality globally and are vaccine preventable. The WHO-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease Surveillance Networks support surveillance systems across WHO regions to provide burden of disease data for countries to make evidence-based decisions about introducing vaccines and to demonstrate the impact of vaccines on disease burden. These surveillance networks help fill the gaps in data in low and middle-income countries where disease burden and risk are high but support to sustain surveillance activities and generate data is low. Through a series of country case studies, this paper reviews the successful use of surveillance data for disease caused by pneumococcus and rotavirus in informing national vaccine policy in Bangladesh, Armenia and The Gambia. The case studies delve into ways in which countries are leveraging and building capacity in existing surveillance infrastructure to monitor other diseases of concern in the country. Local institutions have been identified to play a critical role in making surveillance data available to policymakers. We recommend that countries review local or regional surveillance data in making vaccine policy decisions. Documenting use of surveillance activities can be used as advocacy tools to convince governments and external funders to invest in surveillance and make it a priority immunization activity.
- Published
- 2018
8. Detection of brucellosis through active surveillance, Armenia, 2014
- Author
-
Artavazd Vanyan, Lilit Avetisyan, and Liana Torosyan
- Subjects
education.field_of_study ,Veterinary medicine ,medicine.medical_specialty ,biology ,business.industry ,Population ,Brucellosis ,Disease ,Brucella ,Armenia ,Animal husbandry ,Raw milk ,medicine.disease ,biology.organism_classification ,brucellosis ,Environmental health ,Epidemiology ,surveillance ,medicine ,General Earth and Planetary Sciences ,ISDS 2016 Conference Abstracts ,Risk factor ,education ,business ,General Environmental Science - Abstract
Objective In the spring of 2014, people from vulnerable households in all marzes of Armenia were examined with the aim of active surveillance. Introduction Brucellosis is a serious disease caused by bacteria of the Brucella genus. It principally affects ruminants but may be transmitted to humans. Registration of cases in cattle farms causes considerable economic losses and creates favorable conditions for mass infection among humans. In Armenia the expansion of animal industries and urbanization are the main reasons for occurrence and development of brucellosis. Methods Blood was sampled from people on farms reported as having infected animals. Blood samples were tested by the Wright- Huddleston method. The standard case definition of brucellosis was used for diagnosis. A questionnaire-based interview was carried out among the population to identify the form of contact with animals and to analyze epidemiological links. During the investigation provisions were followed in governmental decree RA 19.01.2006 N480-N and brucellosis prevention, epidemiology, diagnosis, treatment, preventive measures. Results A total of 11160 people from 1054 households were enrolled in the study, of which 3625 (32.5%) underwent a laboratory examination. Nearly 6% (641) refused to be tested. Over 6% of those tested (226) were positive for antibodies to Brucellae. Of these, 129 (3.5%) had chronic brucellosis. Those testing positive for brucellosis were treated appropriately. These included 203 (90%) adults and 23 (10%) below 14 years old; 147 (65%) were male and 79 (35%) were female. Of those diagnosed with brucellosis, working in animal husbandry accounted for 46.6% (106), while those who harvested milk accounted for 37.6% (85) and those using raw milk made up 15.4% (35). Conclusions Cases were most frequently reported among people 20-55 years of age; the highest percentage of positives were among 41-45 year old males who had contact with infected animals. The main risk factor for acquiring brucellosis is animal husbandry.
- Published
- 2017
- Full Text
- View/download PDF
9. Multicountry Analysis of Spectrum of Clinical Manifestations of Children <5 Years of Age Hospitalized with Diarrhea.
- Author
-
Murray, Jillian, Yati Soenarto, S., Mulyani, Nenny S., Wijesinghe, Pushpa S., Mpabalwani, Evans M., Simwaka, Julia C., Matapo, Belem, Mwenda, Jason M., Sahakyan, Gayane, Grigoryan, Svetlana, Vanyan, Artavazd, Khactatryan, Sergey, Sanwogou, Jennifer, de Oliveira, Lúcia Helena, Rey-Benito, Gloria, Kang, Gagandeep, Serhan, Fatima, Tate, Jacqueline E., Aliabadi, Negar, and Cohen, Adam L.
- Subjects
SPECTRUM analysis ,DIARRHEA ,ROTAVIRUS vaccines ,GASTROENTERITIS ,DIAGNOSIS of diarrhea ,DIARRHEA prevention ,PUBLIC health surveillance ,RESEARCH ,IMMUNIZATION ,VACCINES ,RETROVIRUS diseases ,RESEARCH methodology ,EVALUATION research ,MEDICAL cooperation ,MEDICAL protocols ,COMPARATIVE studies ,HOSPITAL care - Abstract
After introduction of rotavirus vaccine, other pathogens might become leading causes of hospitalizations for severe diarrhea among children <5 years of age. Our study in 33 hospitals in 7 countries found acute gastroenteritis accounted for most (84%) reported hospitalizations of children with diarrhea. Bloody and persistent diarrhea each accounted for <1%. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. GIS Analysis of Tularemia Outbreaks in Armenia, 1996-2013
- Author
-
S. Melikjanyan, A. Vanyan, A. Avetisyan, and N. Bakunts
- Subjects
Veterinary medicine ,CBEP ,business.industry ,Outbreak ,ISDS 2013 Conference Abstracts ,Armenia ,medicine.disease ,tularemia ,Tularemia ,medicine ,Retrospective analysis ,General Earth and Planetary Sciences ,Medical emergency ,business ,General Environmental Science - Abstract
We have applied GIS methodologies to create a retrospective analysis of tularemia outbreaks in the Republic of Armenia.
- Published
- 2014
- Full Text
- View/download PDF
11. Reports on establishing an ex situ site for ‘beautiful’ vavilovia (Vavilovia formosa) in Armenia
- Author
-
Mike Ambrose, Aleksandar Mikić, Petr Smýkal, Natalia V. Demidenko, Gregory Kenicer, Andrey A. Sinjushin, M. A. Vishnyakova, Janna Akopian, N. Sarukhanyan, Ivan Gabrielyan, and A. Vanyan
- Subjects
Flora ,Fabeae ,In situ conservation ,biology ,Ecology ,Disjunct distribution ,ex situ conservation ,Plant Science ,Vegetation ,Armenia ,Ex situ conservation ,Tribe (biology) ,biology.organism_classification ,genetic resources ,Vavilovia formosa ,Botany ,Genetics ,‘Beautiful’ vavilovia ,Vavilovia ,Agronomy and Crop Science ,Ecology, Evolution, Behavior and Systematics ,in situ conservation - Abstract
Vavilovia (Vavilovia Fed.) is one of the five genera in tribe Fabeae and consists of only one species, ‘beautiful’ vavilovia (Vavilovia formosa (Stev.) Fed.). The main centre of distribution is the Central and Eastern Caucasus, with a disjunct distribution among high alpine areas in the region, extending as far as West Turkey, Lebanon and Iran. In Armenia, in situ studies on Vavilovia started in the late 1930s. In July and August 2009, three expeditions were conducted to two locations: two to the Ughtasar Mountain and one to the Geghama Mountains. The first expedition to Ughtasar resulted in fresh plant collections and soil analysis for one of the sites. The expedition to Geghama established the existence of Vavilovia in the region of Lake Aknalitch. The second expedition to Ughtasar provided immature fruits and seeds. Collected plant material was transplanted into the Flora and Vegetation of Armenia plot of the Yerevan Botanic Garden established in 1940. Today, along with other plants the plot contains more than 200 species of wild relatives of cultural plants from 130 genera, including indiginous species of tribe Fabeae such as Vavilovia. The transplanted plants will continue to be monitored to see if the plants go on to successfully flower and set seed or whether further sites, possibly at higher altitudes might need to be tested to meet the long term conservation requirements of this iconic legume. These co-ordinated efforts provide a good example of an ex situ conservation strategy for Vavilovia formosa, which, if successful will improve access and utility for the whole legume research community.
- Published
- 2010
12. Impact and Effectiveness of Monovalent Rotavirus Vaccine in Armenian Children.
- Author
-
Sahakyan, Gayane, Grigoryan, Svetlana, Wasley, Annemarie, Mosina, Liudmila, Sargsyan, Shushan, Asoyan, Ara, Gevorgyan, Zaruhi, Kocharyan, Karine, Avagyan, Tigran, Lopman, Benjamin, Vanyan, Artavazd, Khactatryan, Sergey, Parashar, Umesh D., and Cortese, Margaret M.
- Subjects
ROTAVIRUS vaccines ,JUVENILE diseases ,IMMUNIZATION ,GASTROENTERITIS in children ,VACCINE effectiveness - Abstract
Background. The Republic of Armenia was 1 of the 2 earliest countries in the Newly Independent States to introduce rotavirus vaccine into its national immunization program to reduce the burden of rotavirus disease (documented to cause 38% of acute gastroenteritis hospitalizations [AGE] among children aged <5 years). In November 2012, RV1 (Rotarix) was introduced for Armenian infants at ages 6 and 12 weeks. Methods. The established active surveillance system at 2 hospitals in the capital, Yerevan, whereby children aged <5 years hospitalized for AGE have stool sample tested for rotavirus antigen, was used to assess trends in rotavirus hospitalizations. Immunization records on children enrolled after vaccine introduction were obtained from clinics, and vaccine effectiveness (VE) was estimated using children with AGE who test negative for rotavirus as controls for the rotavirus-positive cases. Results. Among infants, rotavirus hospitalizations were reduced by 48% within the first year after introduction, and by ≥75% in years 2 and 3 following introduction. Reductions of ≥30% in other young children too old to have been vaccinated suggest additional benefit through indirect protection; overall in year 3, rotavirus hospitalizations were reduced by 69% among children aged <5 years. The overall VE of 2 RV1 doses in protecting against rotavirus hospitalization (any severity) was 62% (95% confidence interval [CI], 36%–77%) among children aged 6–23 months; 68% (95% CI, 24%–86%) among those aged 6–11 months, and 60% (95% CI, 20%–80%) in children aged 12–23 months. Against more severe rotavirus disease, VE was 79% (95% CI, 55%–90%) and similarly high in both age groups. Conclusions. RV1 is effective in young Armenian children and substantially reduced rotavirus hospitalizations shortly after introduction. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
13. Costs of in- and outpatient respiratory disease and the seasonal influenza vaccination program in Armenia − 2020–2021.
- Author
-
Gobin, Stacie, Sahakyan, Gayane, Kusi Appiah, Michael, Manukyan, Ani, Palayan, Karo, Ebama, Malembe, Vanyan, Artavazd, McCarron, Margaret, and Bresee, Joseph
- Subjects
- *
ECONOMIC aspects of diseases , *ECONOMIC statistics , *CLINICAL pathology , *INFLUENZA vaccines , *MEDICAL care , *SEASONAL influenza - Abstract
Despite the substantial global impact of influenza, there are limited economic data to guide influenza vaccination programs investments in middle-income countries. We measured the costs of influenza and the costs of an influenza vaccination program in Armenia, using a societal perspective. During December 2022 through March 2023, retrospective cost data were collected from case-patients and healthcare providers through structured questionnaires at 15 healthcare facilities selected through stratified sampling. Medical costs included medications, laboratory costs, laboratory and diagnostic tests, and routine health care service costs and direct and indirect societal costs were included. Vaccination program costs from the 2021–2022 influenza season were identified using accounting records and categorized as: planning, distribution, training, social mobilization and outreach, supervision and monitoring, procurement, and national- and facility-level administration and storage. The mean costs per episode for SARI and ILI case-patients were $US 823.6 and $US 616.57, respectively. Healthcare service costs were the largest direct expenses for ILI and SARI case-patients. Total costs of the 2021–2022 influenza vaccination program to the government were $US 4,353,738, with the largest costs associated with national- and facility-level administration and storage (30% and 65% respectively). The total cost per dose administered was $US 25.61 ($US 7.73 per dose for procurement and $US 17.88 for the marginal administration cost per dose). These data on the costs of seasonal influenza prevention programs and the societal costs of influenza illness in Armenia may inform national vaccine policy decisions in Armenia and may be useful for other middle-income countries. Influenza vaccines, like other vaccine programs, are recognized as substantially contributing to the reduction disease burden and associated mortality and further driving economic growth. However, a formal cost-effectiveness analysis should be performed once burden of disease data are available. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. A review of human alveolar echinococcosis in the Republic of Armenia from 2008 to 2020
- Author
-
Ani Manukyan, Lilit Avetisyan, Gayane Sahakyan, Adela Paez Jimenez, Lusine Paronyan, Karine Gevorgyan, and Artavazd Vanyan
- Subjects
Alveolar echinococcosis ,Echinococcus multilocularis ,Armenia ,Registries ,Biopsy ,Infectious and parasitic diseases ,RC109-216 - Abstract
Background: Since the 90s' Echinococcus multilocularis infection has expanded the geographical area and central-eastern European countries had seen first alveolar echinococcosis (AE) human cases. AE is considered to be a very rare disease in Europe with average incidences of 0.03–0.2/100,000 inhabitants/year. Because of a suitable orography, this study aims to confirm whether there are human AE cases in Armenia, identify areas at risk, and also estimate AE annual incidence. Methods: Retrospective AE case finding was carried out at main multi-profile medical centers equipped with the modern diagnostic means. The medical records of all patients with liver surgery admitted between January 2008 and June 2020 were reviewed. A specific form was developed in EpiInfo v.7.2. Annual national incidence was estimated using population denominators provided by the National Institute of Statistics. Results: Overall, 11 AE cases have been identified. All patients were diagnosed at advanced stages, with subsequent poor prognosis and costly treatment. Confirmation was based on tissue biopsy and medical imaging results. Age ranged from 12 to 58 years with a median of 33 yrs. Patients were from rural communities, mostly in the Gegharkunik region (6 cases, 55%). Annual average incidence of AE was 0.033/100,000 varying between 0.032 in 2008 and 0.1 in 2017. Conclusions: There are human AE cases happening in Armenia since more a decade ago. In the absence of an AE surveillance system, the burden of AE disease is difficult to estimate. Development of national AE guidelines with a case definition should help enforcing registry of all cases, early diagnosis and also clinical and public awareness.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.